S3850Temporary National Codes (Non-Medicare)
Genetic testing for sickle cell anemia
Short description: Gene test sickle cell
- Effective date
- July 1, 2003
- Termination date
- —
Related codes (S-series)
S0012Butorphanol tartrate, nasalS0013Esketamine, nasal sprayS0014Tacrine hydrochloride, 10 mgS0017Injection, aminocaproic acidS0020Injection, bupivicaine hydroS0021Injection, cefoperazone sodS0023Injection, cimetidine hydrocS0028Injection, famotidine, 20 mgS0030Injection, metronidazoleS0032Injection, nafcillin sodiumS0034Injection, ofloxacin, 400 mgS0039Injection, sulfamethoxazole
Frequently asked questions
What is HCPCS code S3850?
S3850 is a HCPCS Level II code for Genetic testing for sickle cell anemia.
What category is HCPCS code S3850 in?
S3850 falls under the Temporary National Codes (Non-Medicare) category of HCPCS Level II.
When did HCPCS code S3850 become effective?
S3850 has been effective since July 1, 2003, per CMS's quarterly HCPCS update.
HCPCS Level II data from CMS (public domain). HCPCS Level I (CPT) codes are not included — CPT is copyrighted by the American Medical Association. Always verify codes with authoritative sources before making coding or billing decisions.